MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists train eyes to see around blind spots
Disease control CompletedThis study tested a new training method to help people with macular degeneration, a leading cause of central vision loss. Researchers taught 21 participants to become more aware of their blind spot and use a different, healthier part of their eye to see. The goal was to see if th…
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Study aims to cut down on eye injections for vision loss
Disease control CompletedThis study tested if combining a light-based therapy with a standard eye injection could reduce the number of injections needed to treat wet age-related macular degeneration (AMD). It involved 60 people with this condition, comparing the standard injection schedule to a combined …
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Texas Retina Associates • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Breakthrough eye injection shows promise in slowing blinding disease
Disease control CompletedThis study tested whether a monthly injection into the eye, called avacincaptad pegol (Zimura), could safely slow the progression of geographic atrophy. Geographic atrophy is a severe form of age-related macular degeneration that causes permanent, progressive vision loss. The tri…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: IVERIC bio, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC